Sengenics | Autoantibody Biomarker | Proteomic Technology

Explore Our Technology

Accelerating biomarker discovery and autoantibody profiling by expression and purification of full-length, correctly folded proteins.

Identifying disease-specific autoantigens to facilitate discovery of autoantibody biomarkers.

Learn how the unique characteristics of autoantibodies make them such powerful and predictive biomarkers of disease and therapeutic response.

Learn why a specialized approach to bioinformatics is required for discovering predictive autoantibody biomarker signatures.

Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, therapeutic response prediction and development of companion diagnostics.

Design and development by RainCastle Communications.